Cerebras IPO Pricing Surge

The Cerebras thesis is not 'a faster GPU' - it is that the AI industry's center of gravity has shifted from training models once to running them billions of times per day, and that this shift rewards a fundamentally different chip architecture. Cerebras' Wafer-Scale Engine keeps an entire silicon wafer intact as one giant chip with roughly 900,000 cores rather than dicing the wafer into hundreds of smaller dies as Nvidia does. The company markets the WSE as 58x larger than Nvidia's B200, with 19x more transistors, 250x more on-chip memory and 2,625x more memory bandwidth.

For inference decode - the autoregressive token-by-token step that dominates real-world LLM serving - that on-chip memory bandwidth is the binding constraint, which is why Meta runs Llama 4 inference on Cerebras and why OpenAI signed a multi-year compute deal. CEO Andrew Feldman frames the speed advantage on decode tasks as the explicit reason OpenAI committed. The IPO is effectively the public market's first chance to price the bet that inference, not training, becomes the larger and more durable share of AI compute spend over the next decade.

The headline price-range increase from $115-$125 to $150-$160 is a 28% mid-point bump that, combined with an enlarged 30 million-share offering, lifts targeted proceeds from $3.5 billion to roughly $4.8 billion. The mechanical driver is an order book that exceeded $10 billion - more than 20x oversubscribed - making this on track to be the largest global IPO of 2026 to date per Dealogic.

But the more interesting tell sits in private secondary markets: investor chatter on Reddit surfaced that pre-IPO venues Hiive and Notice had been quoting Cerebras shares at $158 and $187 well before underwriters Morgan Stanley, Citigroup, Barclays and UBS lifted the deal range, meaning sophisticated pre-IPO buyers had already repriced the company above the original deal. Retail sentiment is broadly bullish-but-cautious, with allocations reportedly capped at zero to ten shares per Fidelity, SoFi and E*Trade account; Robinhood and Webull users are excluded entirely. The takeaway: the price-range raise is the public tape catching up to where private markets had already moved, not a fresh revaluation.

OpenAI is not a normal anchor customer - it is structurally entangled with Cerebras in three distinct capacities, and that entanglement is the single largest risk hiding behind the demand story. In January 2026 the two companies signed a multi-year compute deal worth more than $20 billion covering 750 MW of capacity through 2028. One month earlier, in December 2025, OpenAI lent Cerebras $1 billion secured by warrants convertible into more than 33 million shares, making the lab simultaneously the chipmaker's biggest revenue source, a creditor with collateral rights, and a potential top equity holder once those warrants convert.

Two customers accounted for 86% of 2025 revenue. If OpenAI ever invokes termination rights, walks away from the $20B contract, or in-houses inference compute, Cerebras faces simultaneous revenue collapse, loan-repayment pressure, and dilution overhang. The community on r/stocks and TECHi's analysis both flag this concentration as the principal downside risk, and it is what underwriters mean when they note the company must scale manufacturing fast enough to avoid contractual penalties. The same anchor that justifies the 20x oversubscription is the single point of failure investors are asked to underwrite.

Cerebras' headline 2025 numbers look like a profitability inflection - revenue of $510 million up 76% year over year, and a roughly $238 million GAAP net profit. The reality underneath is materially less flattering. TECHi's analysis and corroborating reporting note that the operating business - actually selling WSE systems and running cloud inference - generated a GAAP operating loss of approximately $146 million. The swing to net profit came from a $363 million non-cash accounting gain on a forward contract liability, an artifact of mark-to-market accounting on derivative instruments rather than recurring cash earnings.

That distinction matters at a $26.6 billion valuation because investors are paying roughly 52 times trailing revenue, versus Nvidia at about 30x forward - pricing Cerebras as a pure-play inference compounder where every dollar of headline profit is implicitly extrapolated forward. Skeptical voices on Reddit have already flagged the S-1 profitability question, noting Cerebras is roughly 5x more expensive than Nvidia on a revenue-multiple basis and pointing to historical underperformance of large IPOs in the year after listing. The quality-of-earnings gap is the bridge the public-market thesis has to cross.